Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Discussion of the entities and frameworks responsible for enforcing index rules and governance, including accountability and compliance checks.
28,655 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
International demand for live music is rising, with concert promoters reporting that international fans now outpace d...
HSBC downgraded Trade Desk to Reduce with a $20 target, joining a wave of caution as ad-tech faces a shift toward ret...
NVIDIA’s stock has surged roughly 20% over the past month as markets brace for the May earnings release. Analysts and...
Institutional demand for XRP is rising as ETFs gain approval. Analysts map how much XRP you'd need to reach $1 millio...
Public tours of Jim Henson's Creature Shop in Queens reveal the hidden craft behind Kermit and friends. The 80-minute...
Snowflake posted a record quarter, but its stock trades far from its peak as investors weigh whether AI-driven growth...
A Goldman Sachs AI skeptic warns the market’s patience may be running thin as OpenAI and Anthropic gear up for mega-I...
Crypto markets rebound as ripple’s (xrp) potential and Solana price outlook draw attention. Key on-chain data and ins...
Analysts spotlight five dividend stocks yielding above 5% designed to provide steady income amid market volatility. T...
An Oppenheimer analyst has floated a $10 trillion valuation for SpaceX within five years, anchored by Starlink's cash...
In late June 2026, XRP and XLM are both testing breakout attempts after weeks of consolidation. Neither has confirmed...